docHâepatitis B: A Silent Epidemic What you need to know and what
download 
Report Transcription
Hâepatitis B: A Silent Epidemic What you need to know and what
H epatitis B: A Silent Epidemic What you need to know and what you can do Tuesday, May 19, 2015 12:30 PM - 2:00 PM Senate Dirksen Building, Room G11 Please send RSVP to [email protected] Lunch will be provided. In recognition of National Hepatitis Awareness Month and May 19th National Hepatitis Testing Day, please join us for a briefing on hepatitis B and the elimination of perinatal transmission. Honorary Host Senator Mazie K. Hirono Up to two million people in the U.S. are living with chronic hepatitis B. Hepatitis B can cause liver damage, liver failure and liver cancer. Hepatitis B is 50–100 times more infectious than HIV. Asian Americans and Pacific Islanders (APIs) make up less than 5% of the total population in the United States, but account for more than 50% of Americans living with chronic Hepatitis B. African immigrant communities are also disproportionately affected by this infectious disease with an infection rate of almost 10 percent. When babies become infected with hepatitis B, they have a 90% chance of developing a lifelong, chronic infection. Join this panel of experts to discuss the latest hepatitis B research, education, prevention and treatment programs, and how you can get involved. _______________________________________________________________________________ Speakers: Moderated by Christine Rodriguez, MPH, Public Policy Manager, National Viral Hepatitis Roundtable Hepatitis B Overview Chari Cohen, DrPH, MPH, Director of Public Health, Hepatitis B Foundation Peter Whiticar, Chief, Hawai'i State Department of Health STD/AIDS Prevention Branch Maureen Kamischke, Patient Advocate, Social Media and Outreach Manager, Hepatitis B Foundation Perinatal Hepatitis B Transmission Sarah Schillie, MD, MPH, MBA, Division of Viral Hepatitis, National Center of HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention Julie Lazaroff, MPH, Perinatal Hepatitis B Prevention Unit Chief, New York City Department of Health and Mental Hygiene Lunch will be provided in accordance with Senate rules on widely attended events. __________________________________________________________________________________________
Similar documents
Global Hepatitis B Diagnostic Test Market
Hepatitis B is an infectious disease associated with the inflammation of the liver. Hepatitis B infection is caused due to the Hepatitis B virus (HBV) transmitted from one person to other through infectious blood, semen and other body fluids. Hepatitis B infection can be acute and it may develop into chronic infection if not diagnosed and treated at an early stage. Chronically infected Hepatitis B patients eventually develop liver cirrhosis, hepatocellular carcinoma (liver cancer), fulminant hepatitis B (autoimmune disorder) or suffer from liver failure requiring liver transplant and can even result in death.
